WE-LaunchWindtree Therapeutics has signed a $520 million new financing agreement, which will be used to purchase BNB.
BlockBeats News, July 25th, Nasdaq-listed biotechnology company Windtree Therapeutics (WINT) announced that it has entered into a share purchase agreement of up to $500 million to establish an Equity Line of Credit (ELOC). Additionally, the company has also signed an additional $20 million stock purchase agreement with Build and Build Corp.
The total funding size of this round reaches up to $520 million, with 99% of the funds to be used to purchase BNB. The company plans to officially start using the funds after obtaining shareholder approval to increase the number of authorized common shares.
You may also like
TRUMP Memecoins Unlock Sparks Buzz During Intense Crypto Week Votes on August 11, 2025
As we dive into the heart of what many are calling Crypto Week on this August 11, 2025,…
Discover 5 Surprising Countries Where Crypto Remains Tax-Free in 2025
As of today, August 11, 2025, the world of cryptocurrency continues to evolve rapidly, with Bitcoin hovering around…
Succinct (PROVE) Coin Airdrop: How to Claim $21 Million in Free Tokens by August 2025
I’ve been diving into cryptocurrency airdrops for years, and I still remember my first big win back in…
Honeypot Crypto Scams: The Deceptive Trap That Could Lock Your Investments Away Forever
Imagine wandering into what seems like a thriving marketplace, buzzing with activity and promising quick gains, only to…
WEEX Global Journey 2025: Connecting the World of Web3
WEEX’s H2 2025 global tour is hitting top blockchain stages and exclusive community meetups worldwide — connecting with real builders, sparking honest conversations, and creating lasting trust. Our mission: make trading simpler, confidence stronger, and crypto trusted across the globe.
Gainers
Customer Support：@weikecs
Business Cooperation：@weikecs
Quant Trading & MM：[email protected]
VIP Services：[email protected]
App